The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 01, 2025
Filed:
Dec. 21, 2022
Applicants:
Cdr-life Ag, Schlieren, CH;
Boehringer Ingelheim International Gmbh, Ingelheim am Rhein, DE;
Inventors:
Leonardo Borras, Birmensdorf, CH;
Pankaj Gupta, Scarsdale, NY (US);
Stephanie Jungmichel, Oerlikon-Zuerich, CH;
Christian Leisner, Thalwil, CH;
Philipp Robert Richle, Zurich, CH;
Fabian Scheifele, Maegenwil-Aargau, CH;
Anna Sobieraj, Schlieren, CH;
Assignees:
CDR-Life AG, Schlieren, CH;
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); G01N 33/68 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); G01N 33/6893 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); C07K 2317/24 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); G01N 2333/4716 (2013.01);
Abstract
The present invention relates to antibodies and fragments thereof that target the complement C3. More specifically, anti-C3 antibodies and methods of use for the treatment of various diseases or disorders are disclosed.